Evaluation of the specificity of [18F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [18F]FDG and impact of rituximab therapy

N Hovhannisyan (1, 2) , S Guillouet (2, 1) , F Fillesoye (2, 1) , M Dhilly (2, 1) , D Patin (2, 1) , F Galateau (3) , M Leporrier (2, 1) , Louisa Barré (2, 1)

1 LDM-TEP - Laboratoire de Développements Méthodologiques en Tomographie par Emission de Positons
2 UNICAEN - Université de Caen Normandie
3 Laboratoire d'Anatomie Pathologique [CHU Caen]

Mots clés: PET/CT; Imaging; Lymphoma; Rituximab; [18F]Fludarabine

Domaines: Sciences du Vivant [q-bio]

N Hovhannisyan, S Guillouet, F Fillesoye, M Dhilly, D Patin, et al.. Evaluation of the specificity of [18F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [18F]FDG and impact of rituximab therapy. EJNMMI Research, 2015, 5, pp.23. ⟨10.1186/s13550-015-0101-7⟩. ⟨hal-01577880⟩